HUP0600520A2 - Compositions comprising il-18 and a chemoterapeutic agent for treatment and/or prevention of cancer - Google Patents

Compositions comprising il-18 and a chemoterapeutic agent for treatment and/or prevention of cancer

Info

Publication number
HUP0600520A2
HUP0600520A2 HU0600520A HUP0600520A HUP0600520A2 HU P0600520 A2 HUP0600520 A2 HU P0600520A2 HU 0600520 A HU0600520 A HU 0600520A HU P0600520 A HUP0600520 A HU P0600520A HU P0600520 A2 HUP0600520 A2 HU P0600520A2
Authority
HU
Hungary
Prior art keywords
cancer
prevention
compositions
treatment
chemoterapeutic
Prior art date
Application number
HU0600520A
Other languages
English (en)
Inventor
Randall K Johnson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22199389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0600520(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of HUP0600520A2 publication Critical patent/HUP0600520A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HU0600520A 1998-05-21 1999-05-20 Compositions comprising il-18 and a chemoterapeutic agent for treatment and/or prevention of cancer HUP0600520A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8656098P 1998-05-21 1998-05-21
PCT/US1999/011160 WO1999059565A1 (en) 1998-05-21 1999-05-20 Novel compositions

Publications (1)

Publication Number Publication Date
HUP0600520A2 true HUP0600520A2 (en) 2006-10-28

Family

ID=22199389

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0600520A HUP0600520A2 (en) 1998-05-21 1999-05-20 Compositions comprising il-18 and a chemoterapeutic agent for treatment and/or prevention of cancer

Country Status (28)

Country Link
US (1) US6582689B1 (hu)
EP (1) EP1079818B1 (hu)
JP (1) JP4283998B2 (hu)
KR (1) KR100624588B1 (hu)
CN (1) CN1227027C (hu)
AR (1) AR019844A1 (hu)
AT (1) ATE245440T1 (hu)
AU (1) AU750918B2 (hu)
BR (1) BR9910622A (hu)
CA (1) CA2328603A1 (hu)
CO (1) CO5050337A1 (hu)
CZ (1) CZ300496B6 (hu)
DE (1) DE69909781T2 (hu)
DK (1) DK1079818T3 (hu)
ES (1) ES2204164T3 (hu)
GC (1) GC0000102A (hu)
HK (1) HK1035136A1 (hu)
HU (1) HUP0600520A2 (hu)
IL (2) IL139733A0 (hu)
MY (1) MY123434A (hu)
NO (1) NO329195B1 (hu)
NZ (1) NZ508115A (hu)
PL (1) PL200840B1 (hu)
PT (1) PT1079818E (hu)
TR (1) TR200003453T2 (hu)
TW (1) TWI227136B (hu)
WO (1) WO1999059565A1 (hu)
ZA (1) ZA200006675B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002324249B2 (en) * 2001-03-08 2007-04-05 Ares Trading S.A. Interleukin-18 mutants, their production and use
US20050079153A1 (en) * 2002-08-14 2005-04-14 Pfizer Inc. Methods for enhancing immune functions in neonatal mammals by administration of IL-18
EP1572228A4 (en) * 2002-09-19 2009-03-04 Centocor Inc METHOD FOR INDUCING MATURATION OF DENDRITIC CELLS AND USES THEREOF
ES2322605T3 (es) * 2004-08-20 2009-06-23 Smithkline Beecham Corporation Tratamiento de la mucositis oral e intestinal mediante la administracion de il-18 humano.
EP2059253A4 (en) * 2006-09-14 2011-09-14 Univ Pennsylvania MODULATION OF REGULATORY T CELLS BY HUMAN IL-18
PE20090190A1 (es) * 2007-03-23 2009-03-22 Smithkline Beecham Corp Combinacion de anticuerpos anti-cd20 y polipeptidos de il-18
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
US8168165B2 (en) * 2008-12-23 2012-05-01 Abbott Laboratories Alkylated interleukin-18 compositions
TW201506402A (zh) * 2013-08-15 2015-02-16 Tonyar Biotech Inc 自體防潮的檢驗芯片及其製造方法
US20190070262A1 (en) * 2017-09-06 2019-03-07 Yale University Interleukin-18 variants and methods of use
IL302517A (en) 2020-11-02 2023-07-01 Simcha Il 18 Inc Variants of interleukin-18 and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
JP4004088B2 (ja) 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
TW581771B (en) 1994-11-15 2004-04-01 Hayashibara Biochem Lab Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide
US6207641B1 (en) * 1995-03-10 2001-03-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
US5869535A (en) * 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
JP4024366B2 (ja) 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド

Also Published As

Publication number Publication date
CA2328603A1 (en) 1999-11-25
DE69909781T2 (de) 2004-05-27
NZ508115A (en) 2003-12-19
PL200840B1 (pl) 2009-02-27
AU750918B2 (en) 2002-08-01
PL366170A1 (en) 2005-01-24
ES2204164T3 (es) 2004-04-16
CZ300496B6 (cs) 2009-06-03
NO20005857D0 (no) 2000-11-20
GC0000102A (en) 2005-06-29
CN1227027C (zh) 2005-11-16
CZ20004321A3 (en) 2001-05-16
JP2003509333A (ja) 2003-03-11
JP4283998B2 (ja) 2009-06-24
CO5050337A1 (es) 2001-06-27
PT1079818E (pt) 2004-02-27
EP1079818A1 (en) 2001-03-07
AR019844A1 (es) 2002-03-20
WO1999059565A1 (en) 1999-11-25
NO329195B1 (no) 2010-09-13
KR20010052369A (ko) 2001-06-25
IL139733A0 (en) 2002-02-10
TR200003453T2 (tr) 2001-10-22
TWI227136B (en) 2005-02-01
EP1079818A4 (en) 2001-12-12
KR100624588B1 (ko) 2006-09-18
ATE245440T1 (de) 2003-08-15
ZA200006675B (en) 2002-02-27
DE69909781D1 (de) 2003-08-28
MY123434A (en) 2006-05-31
EP1079818B1 (en) 2003-07-23
IL139733A (en) 2009-06-15
HK1035136A1 (en) 2001-11-16
AU4309499A (en) 1999-12-06
CN1367686A (zh) 2002-09-04
DK1079818T3 (da) 2004-04-19
NO20005857L (no) 2000-11-21
US6582689B1 (en) 2003-06-24
BR9910622A (pt) 2001-01-30

Similar Documents

Publication Publication Date Title
HUP0103920A3 (en) Methods and compositions for the prevention and treatment of anemia
IL140845A0 (en) Compositions for therapy and diagnosis of prostate cancer
AU6147401A (en) Compositions and methods for the treatment of cancer
HK1049787B (zh) 採用免疫共軛物和化療劑治療癌症的組合物以及方法
GB9903841D0 (en) Diagnosis and treatment of cancer
PL349322A1 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
HK1037303A1 (en) Compositions and methods for treatment of mitochondrial diseases
IL127664A (en) Compositions for the treatment and prevention of cachexia
IL142906A0 (en) Methods and compositions for treating or preventing peripheral neuropathies
PL352931A1 (en) Compositions and uses of et743 for treating cancer
HUP0104688A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
HK1043019B (zh) 用於預防和治療原蟲病的組合物和方法
ZA200208228B (en) Use of il-18 inhibitors for the treatment and/or prevention of athesclerosis
HUP0600520A2 (en) Compositions comprising il-18 and a chemoterapeutic agent for treatment and/or prevention of cancer
AU6435398A (en) Prevention and treatment of hepatocellular cancer
IL158206A0 (en) Compositions and methods for the prevention and treatment of human prostate cancer
IL124650A0 (en) Methods and therapeutic compositions for treating cancer
GB9811598D0 (en) Diagnosis and treatment of cancer
IL138692A0 (en) Treatment and prevention of vascular disease
IL141426A0 (en) Compositions and methods for the treatment of tumor
IL143212A0 (en) Compositions and methods for the treatment of tumor
IL154354A0 (en) Composition for prophylaxis and treatment of cancer
IL147410A0 (en) L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases
EP1259255A4 (en) PAI-2 CONJUGATES FOR THE TREATMENT AND VISUALIZATION OF CANCERS
GB9819999D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees